Group | N | Gestational age (weeks) | RVEDV (mL) | RVESV (mL) | RVSV (mL) | RVCO (mL/min) | RVEF (%) |
---|---|---|---|---|---|---|---|
Control | 151 | 30.16 ± 3.85 | 3.54 ± 1.50 | 1.33 ± 0.56 | 2.21 ± 0.97 | 321.89 ± 142.02 | 62.31 ± 4.15 |
HLHS-LV cavity visible | 26 | 29.12 ± 3.54 | 4.18 ± 1.52* | 1.88 ± 0.99* | 2.30 ± 0.80* | 337.89 ± 113.65* | 56.74 ± 11.05* |
HLHS-LV cavity invisible | 13 | 29.50 ± 3.20 | 4.55 ± 1.39* | 1.93 ± 0.70* | 2.62 ± 0.83* | 377.46 ± 124.96* | 57.38 ± 6.99* |